Romney, Ryan and Medicare Rights

Article

The Medicare Rights Center, a national, nonprofit consumer service organization, sent out their e-newsletter this week with some troubling news about the Romney-Ryan plan for Medicare. The Center from what I can see gets its funding from a variety of sources and does not appear to be partisan. If it is, please let me know because that's not what this is about. It's about Medicare.What the newsletter said was this: The Romney-Ryan plan will increase Medicare costs now and in the future. The Center based the comments on a report by the Center for American Progress (CAP), which also professes to be bipartisan. And it gives the web page so you can read the whole report for yourself. But here are the high points. 1. The RR budget proposal increases Medicare premiums and drug costs for current seniors and increases Medicare costs during retirement for those who qualify for Medicare after 2011.2. Specifically the plan converts the traditional Medicare program into a voucher system, repeals the Affordable Care Act(ACA),and turns Medicaid into a block grant.3. CAP says these changes would significantly increase health care costs for both current and future Medicare recipients. 4. Younger people would face the most cuts under the RR plan with increases of almost $60,000 for people who turn 65 in 2023. Each year the voucher would grow at a rate of .5 percent over the rate of gross domestic product (GDP).5. Because health care costs will increase much faster than the voucher, seniors will be forced to spend more of their own money.Go in and read the whole report "Increased Costs During Retirement Under the Romney-Ryan Medicare Plan." I know many of you support this ticket, so explain the other side that can't be seen. I really want to understand this, as do many of our readers, and we all know that Medicare has been a hot potato in this election. So explain what is not clear here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content